vs

Side-by-side financial comparison of CENTURY CASINOS INC (CNTY) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.

CENTURY CASINOS INC is the larger business by last-quarter revenue ($138.0M vs $85.1M, roughly 1.6× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -13.0%, a 35.8% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 0.2%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-4.7M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 0.7%).

Century Casinos, Inc. is a gambling company based in Colorado Springs, Colorado.

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

CNTY vs FDMT — Head-to-Head

Bigger by revenue
CNTY
CNTY
1.6× larger
CNTY
$138.0M
$85.1M
FDMT
Growing faster (revenue YoY)
FDMT
FDMT
+8508899.8% gap
FDMT
8508900.0%
0.2%
CNTY
Higher net margin
FDMT
FDMT
35.8% more per $
FDMT
22.8%
-13.0%
CNTY
More free cash flow
FDMT
FDMT
$33.2M more FCF
FDMT
$28.5M
$-4.7M
CNTY
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
0.7%
CNTY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CNTY
CNTY
FDMT
FDMT
Revenue
$138.0M
$85.1M
Net Profit
$-17.9M
$19.4M
Gross Margin
Operating Margin
7.6%
17.3%
Net Margin
-13.0%
22.8%
Revenue YoY
0.2%
8508900.0%
Net Profit YoY
80.1%
139.1%
EPS (diluted)
$-0.62
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNTY
CNTY
FDMT
FDMT
Q4 25
$138.0M
$85.1M
Q3 25
$153.7M
$90.0K
Q2 25
$150.8M
$15.0K
Q1 25
$130.4M
$14.0K
Q4 24
$137.8M
$1.0K
Q3 24
$155.7M
$3.0K
Q2 24
$146.4M
$5.0K
Q1 24
$136.0M
$28.0K
Net Profit
CNTY
CNTY
FDMT
FDMT
Q4 25
$-17.9M
$19.4M
Q3 25
$-10.5M
$-56.9M
Q2 25
$-12.3M
$-54.7M
Q1 25
$-20.6M
$-48.0M
Q4 24
$-90.3M
Q3 24
$-8.1M
$-43.8M
Q2 24
$-41.6M
$-35.0M
Q1 24
$-13.5M
$-32.4M
Operating Margin
CNTY
CNTY
FDMT
FDMT
Q4 25
7.6%
17.3%
Q3 25
11.1%
-67983.3%
Q2 25
11.0%
-396373.3%
Q1 25
5.5%
-383007.1%
Q4 24
-45.5%
Q3 24
11.5%
-1704400.0%
Q2 24
9.7%
-849120.0%
Q1 24
6.1%
-136200.0%
Net Margin
CNTY
CNTY
FDMT
FDMT
Q4 25
-13.0%
22.8%
Q3 25
-6.9%
-63195.6%
Q2 25
-8.2%
-364386.7%
Q1 25
-15.8%
-342657.1%
Q4 24
-65.6%
Q3 24
-5.2%
-1461433.3%
Q2 24
-28.4%
-699060.0%
Q1 24
-10.0%
-115717.9%
EPS (diluted)
CNTY
CNTY
FDMT
FDMT
Q4 25
$-0.62
$0.43
Q3 25
$-0.35
$-1.01
Q2 25
$-0.40
$-0.98
Q1 25
$-0.67
$-0.86
Q4 24
$-2.95
Q3 24
$-0.26
$-0.79
Q2 24
$-1.36
$-0.63
Q1 24
$-0.45
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNTY
CNTY
FDMT
FDMT
Cash + ST InvestmentsLiquidity on hand
$68.9M
$402.7M
Total DebtLower is stronger
$328.9M
Stockholders' EquityBook value
$-97.7M
$505.7M
Total Assets
$1.1B
$566.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNTY
CNTY
FDMT
FDMT
Q4 25
$68.9M
$402.7M
Q3 25
$77.7M
$305.1M
Q2 25
$85.5M
$293.2M
Q1 25
$84.7M
$321.4M
Q4 24
$98.8M
$424.9M
Q3 24
$118.8M
$501.9M
Q2 24
$123.2M
$541.9M
Q1 24
$136.5M
$525.9M
Total Debt
CNTY
CNTY
FDMT
FDMT
Q4 25
$328.9M
Q3 25
$329.3M
Q2 25
$328.0M
Q1 25
$328.8M
Q4 24
$328.2M
Q3 24
$327.5M
Q2 24
$328.8M
Q1 24
$328.5M
Stockholders' Equity
CNTY
CNTY
FDMT
FDMT
Q4 25
$-97.7M
$505.7M
Q3 25
$-78.6M
$369.0M
Q2 25
$-66.9M
$420.9M
Q1 25
$-54.3M
$469.7M
Q4 24
$-34.7M
$510.6M
Q3 24
$56.8M
$552.9M
Q2 24
$64.6M
$588.3M
Q1 24
$106.1M
$600.6M
Total Assets
CNTY
CNTY
FDMT
FDMT
Q4 25
$1.1B
$566.7M
Q3 25
$1.2B
$424.0M
Q2 25
$1.2B
$473.6M
Q1 25
$1.2B
$515.7M
Q4 24
$1.2B
$560.4M
Q3 24
$1.3B
$604.0M
Q2 24
$1.3B
$620.1M
Q1 24
$1.3B
$629.9M
Debt / Equity
CNTY
CNTY
FDMT
FDMT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
5.77×
Q2 24
5.09×
Q1 24
3.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNTY
CNTY
FDMT
FDMT
Operating Cash FlowLast quarter
$-114.0K
$28.6M
Free Cash FlowOCF − Capex
$-4.7M
$28.5M
FCF MarginFCF / Revenue
-3.4%
33.5%
Capex IntensityCapex / Revenue
3.3%
0.1%
Cash ConversionOCF / Net Profit
1.47×
TTM Free Cash FlowTrailing 4 quarters
$-15.3M
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNTY
CNTY
FDMT
FDMT
Q4 25
$-114.0K
$28.6M
Q3 25
$144.0K
$-46.5M
Q2 25
$11.3M
$-43.4M
Q1 25
$-4.6M
$-47.8M
Q4 24
$-2.3M
$-134.6M
Q3 24
$7.4M
$-29.4M
Q2 24
$3.0M
$-30.2M
Q1 24
$-11.5M
$-29.1M
Free Cash Flow
CNTY
CNTY
FDMT
FDMT
Q4 25
$-4.7M
$28.5M
Q3 25
$-4.7M
$-46.6M
Q2 25
$5.5M
$-43.4M
Q1 25
$-11.3M
$-48.4M
Q4 24
$-16.9M
$-138.4M
Q3 24
$-2.8M
$-31.2M
Q2 24
$-12.9M
$-30.6M
Q1 24
$-29.9M
$-29.8M
FCF Margin
CNTY
CNTY
FDMT
FDMT
Q4 25
-3.4%
33.5%
Q3 25
-3.1%
-51765.6%
Q2 25
3.6%
-289620.0%
Q1 25
-8.7%
-345635.7%
Q4 24
-12.3%
-13837100.0%
Q3 24
-1.8%
-1038966.7%
Q2 24
-8.8%
-611840.0%
Q1 24
-22.0%
-106421.4%
Capex Intensity
CNTY
CNTY
FDMT
FDMT
Q4 25
3.3%
0.1%
Q3 25
3.2%
101.1%
Q2 25
3.9%
440.0%
Q1 25
5.1%
4507.1%
Q4 24
10.7%
378600.0%
Q3 24
6.6%
59266.7%
Q2 24
10.9%
6980.0%
Q1 24
13.5%
2535.7%
Cash Conversion
CNTY
CNTY
FDMT
FDMT
Q4 25
1.47×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNTY
CNTY

Gaming$103.9M75%
Food And Beverage$13.2M10%
Hotel$10.5M8%
Other$5.2M4%
Pari Mutuel And Sports Betting And Igaming$5.2M4%

FDMT
FDMT

Segment breakdown not available.

Related Comparisons